Efficacy of Entecavir therapy in elderly patients with chronic hepatitis B infection

Tan, You-wen; Ge, Guo-hong; Sun, Li; Zhou, Xing-bei; Peng, Pen-li; Chen, Li.
Braz. j. infect. dis ; 18(6): 691-692, Nov-Dec/2014. tab
Artículo en Inglés | LILACS | ID: lil-730418

Documentos relacionados

  1. Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B.
  2. Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
  3. Renal safety of tenofovir disoproxil fumarate and entecavir with hepatitis B immunoglobulin in liver transplant patients.
  4. [Evaluation of Histological Response in Chronic Hepatitis B Patients with Tenofovir or Entecavir Therapy].
  5. Entecavir-resistant hepatitis B virus decreases surface antigenicity: A full genome and functional characterization.
  6. [Predictive value of liver pathologic changes in determining the effectiveness of entecavir treatment for chronic hepatitis B-An analysis of 1 366 cases].
  7. Long-term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients-Functional cure unlikely.
  8. Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation.
  9. New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment.
  10. [Study on early predictive factors of an incomplete viral response with 48 week-entecavir therapy in HBeAg-positive chronic hepatitis B patients].